Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC)
| Status: | Completed |
|---|---|
| Conditions: | Colitis, Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - 80 |
| Updated: | 4/21/2016 |
| Start Date: | August 2012 |
| End Date: | November 2015 |
The purpose of this protocol is:
1. To quantify the prevalence of adherence to topical mesalamine in patients with UC
2. To describe the determinants of medication adherence in patients with UC prescribed
topical mesalamine
1. To quantify the prevalence of adherence to topical mesalamine in patients with UC
2. To describe the determinants of medication adherence in patients with UC prescribed
topical mesalamine
Patient adherence with topical mesalamine is low. Behavioral and psycho-social barriers to
topical mesalamine adherence exist in patients with UC. These factors can be identified
using qualitative testing in order to develop and design appropriate behavioral
interventions to reduce non-adherence.
The investigators will undertake an observational study of medication persistence in 100
patients in the BIDMC clinic, "Persistence Cohort". Persistence will be measured using
12-month pharmacy refill data. The investigators will also employ a qualitative research
design with discrete choice modeling in two phases: Phase I - Initial Interviews with 10
patients and Phase II - Focus Groups (2) with 5 patients each.
topical mesalamine adherence exist in patients with UC. These factors can be identified
using qualitative testing in order to develop and design appropriate behavioral
interventions to reduce non-adherence.
The investigators will undertake an observational study of medication persistence in 100
patients in the BIDMC clinic, "Persistence Cohort". Persistence will be measured using
12-month pharmacy refill data. The investigators will also employ a qualitative research
design with discrete choice modeling in two phases: Phase I - Initial Interviews with 10
patients and Phase II - Focus Groups (2) with 5 patients each.
Inclusion Criteria:
- must have ulcerative colitis diagnosed by a doctor at least 1 month prior to study
participation
- must be prescribed topical mesalamine (e.g. Rowasa enemas or Canasa suppositories) by
a doctor
- must be receiving care at Beth Israel Deaconess Medical Center
Exclusion Criteria:
- no diagnosis of ulcerative colitis
- no prescription for topical mesalamine
- not receiving care at Beth Israel Deaconess Medical Center
We found this trial at
1
site
Beth Israel Deaconess Medical Center Beth Israel Deaconess Medical Center (BIDMC) is one of the...
Click here to add this to my saved trials
